These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33380151)

  • 21. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ; Ferner RE; Bailey CJ
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion of the EXAMINE study in a meta-analysis of the addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia.
    Boucaud-Maitre D
    BMJ; 2016 Jun; 353():i3186. PubMed ID: 27267596
    [No Abstract]   [Full Text] [Related]  

  • 23. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.
    Quilliam BJ; Ozbay AB; Sill BE; Kogut SJ
    Diabet Med; 2013 Nov; 30(11):1305-13. PubMed ID: 23586474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying factors associated with hypoglycemia-related hospitalizations among elderly patients with T2DM in the US: a novel approach using influential variable analysis.
    Fu H; Xie W; Curtis B; Schuster D
    Curr Med Res Opin; 2014 Sep; 30(9):1787-93. PubMed ID: 24810150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced hypoglycaemia in type 2 diabetes.
    Inkster B; Zammitt NN; Frier BM
    Expert Opin Drug Saf; 2012 Jul; 11(4):597-614. PubMed ID: 22690846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A general view of epidemiology of hypoglycemia in type 1 and type 2 diabetes mellitus.
    Brož J; Urbanová J
    Vnitr Lek; 2019; 65(4):289-294. PubMed ID: 31091949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycaemia in Type 2 diabetes.
    Amiel SA; Dixon T; Mann R; Jameson K
    Diabet Med; 2008 Mar; 25(3):245-54. PubMed ID: 18215172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do sulphonylureas still have a place in clinical practice?
    Khunti K; Chatterjee S; Gerstein HC; Zoungas S; Davies MJ
    Lancet Diabetes Endocrinol; 2018 Oct; 6(10):821-832. PubMed ID: 29501322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe hypoglycaemia among patients with type 2 diabetes requiring emergency hospital admission: The Hypoglycaemia In Portugal Observational Study-Emergency Room (HIPOS-ER).
    Conceição J; Dores J; Araújo F; Laires PA; Carr RD; Brodovicz K; Radican L; Nogueira AM
    Diabetes Obes Metab; 2018 Jan; 20(1):50-59. PubMed ID: 28581253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of sulphonylureas in the elderly.
    Graal MB; Wolffenbuttel BH
    Drugs Aging; 1999 Dec; 15(6):471-81. PubMed ID: 10641958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
    Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
    J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes.
    Barnett AH; Cradock S; Fisher M; Hall G; Hughes E; Middleton A
    Int J Clin Pract; 2010 Jul; 64(8):1121-9. PubMed ID: 20236369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.
    Ragia G; Petridis I; Tavridou A; Christakidis D; Manolopoulos VG
    Pharmacogenomics; 2009 Nov; 10(11):1781-7. PubMed ID: 19891554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulphonylurea-induced hypoglycaemia in institutionalized elderly in Hong Kong.
    So WY; Chan JC; Yeung VT; Chow CC; Ko GT; Li JK; Cockram CS
    Diabet Med; 2002 Nov; 19(11):966-8. PubMed ID: 12421437
    [No Abstract]   [Full Text] [Related]  

  • 37. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
    Earle KE; Rushakoff RJ; Goldfine ID
    Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.